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Objectives: Cocaine is a commonly used illicit drug that leads to the most emergency
department (ED) visits. Chest pain is the most common presentation, reported in 40% of
patients. Our aimwas to evaluate the incidence of previous myocardial infarction among
young cocaine users (18–40 years) with cocaine-associated chest pain by the assessment
of myocardial fibrosis by cardiovascular MRI. Second, we also intended to evaluate the
coronary tree by CT angiography (CTA).
Methods: 24 cocaine users (22 males) who frequently complained about cocaine-
associated chest pain underwent CTA and cardiovascular MRI. Mean age of patients
was 29.7 years and most of them (79%) had frequently used inhalatory cocaine.
Results: The calcium score turned out to be positive in only one patient
(Agatston554). Among the coronary segments evaluated, only one patient had
calcified plaques at the anterior descending coronary artery (proximal and medium
segments). Assessment of regional ventricular function by the evaluation of 17
segments was normal in all patients. None of the patients showed myocardial delayed
enhancement, indicative of myocardial fibrosis. CTA therefore confirmed the low
cardiovascular risk of these patients, since most of them (96%) had no atherosclerosis
detected by this examination. Only one patient (4%) had coronary atherosclerosis
detected, without significant coronary stenosis.
Conclusion: Cardiovascular MR did not detect the presence of delayed enhancement
indicative of myocardial fibrosis among young cocaine users with low cardiovascular
risk who had complained of cocaine-associated chest pain.
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Cocaine is a commonly used illicit drug, used world-
wide by more than 15 million people in 2009 [1], and the
drug that leads to the most emergency department (ED)
visits [2]. Chest pain is the most common presenta-
tion, reported in 40% of patients [3, 4]. Cocaine-related
cardiovascular complications include acute myocardial
infarction (MI), arrythmias, sudden death, myocarditis,
cardiomyopathy, hypertensive crises, aortic dissection
and endocarditis [5, 6]. The majority of patients with
cocaine-associated MI events appear to be young, non-
white smokers with a history of drug use in the pre-
ceding 24h [6, 7]. These characteristics are similar in
patients with cocaine-associated chest pain [8], making it
difficult to predict those at risk for MI, given the rela-
tively low incidence of cocaine-associated MI [8–11].
In recent years, MRI and CT angiography (CTA) have
emerged as powerful non-invasive tools for myocardial
assessment and evaluation of the coronary tree [12–14],
which might be very important in this special scenario.
The aim of this study was to evaluate the incidence of
previous MI among young cocaine users with a history of
chest pain through the diagnosis of myocardial fibrosis
(MF) by MRI. A secondary aim was the assessment of the
coronary tree by CTA.
Methods
We performed a prospective pilot study including
outpatients from the Interdisciplinary Study Group in
Alcohol and Drugs (GREA) of the Institute of Psychiatry
at the University of Sa˜o Paulo Medical School. During
the period from August 2008 to January 2009, from 100
outpatients who were cocaine users, we selected 52
patients with drug-associated chest pain (several epi-
sodes with more than 20min duration), aged between
18 and 40 years and no risk factors for coronary heart
disease. 28 individuals from the sample of 52 subjects
did not participate due to a number of reasons, such as
lack of commitment, refusal to participate in the study
and contact misinformation. Therefore, we studied 24
patients with complaints of cocaine-associated chest pain
(during or shortly after its use), and without emer-
gency department admission. None of the patients had
exclusion criteria for MRI or CTA studies [12–14]. The
study was approved by the Institutional Ethics Com-
mittee, and all patients gave written informed consent.
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MRI data acquisition and analyses
Cardiac MRI images were acquired by a 1.5 T clinical
scanner (Signa CV/i; GE Medical Systems, Waukesha,
WI). After localisation of the heart, 8–12 contiguous
short-axis slices encompassing the entire left ventricle
(LV) and 4 long-axis slices were prescribed. Cine images
were acquired with a steady-state free precession pulse
sequence. Delayed-enhancement images were acquired
5–15min after a bolus injection of 0.2mmol kg–1
(Magnevistan; Schering AG, Berlin, Germany), with an
inversion recovery fast gradient-echo pulse sequence
[12, 13]. Inversion time was adjusted visually to null the
signal of normal myocardium. All MRI analyses were
performed in a commercially available workstation
(ReportCARD; GE Medical Systems, Waukesha, WI).
Cine images were used for assessment of LV volumes,
mass and function. Quantification ofMF byMRIwas based
on the assessment of the short-axis delayed-enhancement
images. The criteria for MF regions were defined as areas
of pixels with higher signal intensity (SI) at least two stan-
dard deviations above a mean SI of a remote area.
Acquisition and analysis of data from multidetector
CT angiography
CT studies were performed in a 64-slice scanner
(Aquilion 64; Toshiba, Ottawara, Japan). Calcium scoring
was performed with the use of prospective electrocar-
diographic (ECG) gating with 400ms gantry rotation,
100–120 kV tube voltage and 300mA tube current. For
multidetector CTA, retrospective ECG gating was used,
with heart rate-adjusted gantry rotations of 350–500ms
to enable adaptive multisegmented reconstruction [14].
Pitch and tube currents of 240–400mA were determined
by patients’ weight to ensure the lowest individual
radiation dose (6–10mSv). Sublingual nitrates were given
before multidetector CTA, along with intravenous con-
trast (Iopamiron 370; Schering AG, Berlin, Germany) at an
injection rate of 5ml s–1 (mean volume 70–85ml) using a
power injector (Stellant; Medrad, Indianola, PA), followed
by a flush of 40ml of saline at a rate of 5ml s–1. Beta-
blockers (intravenous metoprolol in 5–15mg dose) were
given, if the heart rate was above 70 beats per minute.
Multisegmented reconstruction was performed with
0.5mm slice thickness, 0.3mm overlap, multiple phases
and ECG editing [14]. Two independent and experienced
observers reviewed MRI and CTA images, and eventual
discrepancies were solved by consensus. Descriptive
statistics were provided as mean¡standard deviation for
continuous values, and as absolute and relative fre-
quency for categorical values using a commercially
available software (SPSS v. 17.0, IBM, Armonk, NY;
Excel 2007, Microsoft Corporation, Redmond, WA).
Results
24 young patients (mean age 29.7 years; 22 males) were
enrolled in the protocol and underwent MRI and CTA
studies. Clinical data are listed in Table 1. All patients
had complaints of chest pain and no risk factors for
coronary heart disease other than cigarette smoking.
Only 21% of the patients (5 of 24) did not report a
smoking history. 71% of the patients (17 of 24) reported
marijuana abuse, most of them on a frequent basis (more
than 10 times a month). 96% of the patients (23 of 24)
used cocaine in inhalatory form, and 79% of them (19 of
24) reported a frequency of more than 20 times a month.
The non-inhalatory user reported only crack abuse. 71%
of the patients reported crack use (17 of 24). It is notable
that 42% of the patients (10 of 24) reported use of cocaine
in both inhalatory and crack form on a frequent basis.
The calcium score was zero in all but one patient
(Agatston554; volume, 56; Figure 1). None of them
showed significant coronary stenosis evaluated by CTA
scans. Among the coronary segments evaluated, only
one patient showed calcified plaques at the anterior
descending coronary artery (proximal and medium
segments; Figure 2). The overall analysis of the left
ventricular function showed ejection fraction (EF), end
diastolic volume (EDV), end systolic volume (ESV) and
ventricular mass considered normal in all patients. Mean
EF, EDV and ESV were 60.7%, 147.7 ml and 59.1 ml,
respectively. The cardiac index was normal in all
patients. None of the patients presented myocardial
hypertrophy. Assessment regional ventricular function
by the evaluation of 17 segments was normal in all
patients. None of the patients showed myocardial
delayed enhancement, indicative of MF (Figure 3).
Discussion
To the best of our knowledge, this study is the first to
assess previous MI in young cocaine users without risk
factors for coronary artery disease who complained about
chest pain, using CTA and cardiovascular MRI as
diagnostic tools. These patients frequently complained
about cocaine-associated chest pain (several episodes
related to the use of the drug for more than 20min),
without emergency department admissions. Despite this,
we have not found myocardial delayed-enhancement
indicative of MF (from previous acute MI) in any of them.
The CTA results reinforced the low risk profile of these
individuals, since there was only one patient with small
calcified plaques at the anterior descending coronary artery.
Cocaine use is concentrated among a select population
of young individuals, more males than females [15].
These young patients have low thrombolysis in MI risk
score for CAD; therefore most of them do not require
hospitalisation because of their complaints of chest pain.
Table 1. Clinical data
Patient details Patients (n524)
Male 22 (92%)
Female 2 (8%)
White race 22 (92%)
Black race 2 (8%)
Tabagism 19 (79%)
Body mass index ,25 17 (71%)
Body mass index .25 7 (29%)
Alcoholism 7 (29%)
Sedentarism 11 (46%)
Active 13 (54%)
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In the present study, most of the patients were male
(91.6%), with mean age of 29.7 years, which matches the
known profile of cocaine users. This age range is at a low
risk for CAD according to the Framingham criteria [16].
The only risk factor for CAD was cigarette smoking,
found in 79% of our patients (.20 cigarettes a day). It is
also interesting to notice that several patients reported
frequent use of marijuana (71%) and alcohol (96%), drugs
that usually precede and lead to cocaine use. All
individuals reported cocaine ingestion in inhalatory or
crack forms, and 42% of them reported frequent
ingestion of both forms. The low risk profile of our
sample was corroborated by the CTA results, since just
one patient had a positive calcium score (Agatston554)
and small calcified plaques in the anterior left descend-
ing artery.
Cocaine use is highly prevalent in young patients who
present acute chest pain to the ED [6] and it is known
to cause myocardial ischaemia in a multifactor fashion,
including increased oxygen demand, decreased oxygen
supply and the induction of a prothrombotic state [17–20].
Although pathophysiological effects of cocaine are
well documented, its effect on the formation of athero-
sclerosis is controversial. Kolodgie et al [21] found that
30-year-old cocaine users already had significant cor-
onary atherosclerosis. Small autopsy studies suggest that
atherosclerotic plaque burden is high in cocaine users
[22], and there is some evidence that cocaine causes endo-
thelial damage, therefore accelerating atherosclerosis [23].
Lai et al [24] reported a borderline significant associa-
tion between cocaine use and extent of coronary calcifica-
tion in 197 intravenous drug users. Pletcher et al [25] did
(a) (b)
Figure 1. Calcium score showing no (a) calcified plaques and (b) a calcified plaque at the left descending artery.
Figure 2. Coronary anatomy showing
normal three- and two-dimensional
images (top), and three- and two-
dimensional images showing proxi-
mal calcified plaques (bottom).
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not detect an association between cocaine exposure and
the extent of coronary calcification in the Coronary Risk
Development in Young Adults (CARDIA) study, which
enrolled 3038 participants. Bamberg et al [26] confirmed
these observations, and demonstrated no association
between history of cocaine use and coronary calcification
for the presence and extent of calcified and non-calcified
plaques. They also found that in patients presenting with
acute chest pain history of cocaine use is associated with
a six fold increase in risk for acute coronary syndrome
[26].
The overall literature with imaging diagnostic tools
for this matter has little available data [24–27]. In these
studies, the mean age of the patients was higher, with
other risk factors for CAD involved, in contrast to the
population of this study, which were very young (mean
age 29.7 years). In this population, since the CTA results
excluded the presence of atheromatosis in most of the
patients, it is more likely that the chest pain could be
associated with a vasospasm mechanism caused by the
drug. Its importance is, therefore, to highlight the low
risk profile of these patients and avoid survey of CAD of
atherosclerotic origin focusing on diagnostic imaging
confirmation of the absence of vascular disease in young
patients, low risk and cocaine users presenting with chest
pain at the ED.
MRI did not detect MF due to any previous acute MI in
these patients. Therefore, we might conclude that even
though they reported prolonged chest pain, it did not
cause irreversible myocardial damage. The literature
reports a 6% incidence of acute MI among cocaine users
who have chest pain and seekmedical emergency services
[21]. In this study, most patients (90%) did not visit an
emergency department due to chest pain.
In conclusion, cardiovascular MRI did not detect the
presence of delayed enhancement indicative of MF
among young cocaine users with low cardiovascular
risk with complaints of chest pain during or after cocaine
abuse. CTA confirmed low conventional cardiovascular
risk for these patients, since most of them (96%) had no
atherosclerosis detected by this examination.
Limitations
A limitation of this study was the number of patients
enrolled. Access to these individuals is very difficult
because of the illegal nature of their activity. Owing to
the recruitment of patients, the incidence of MI may have
been underestimated. This method was intended to
diagnose MI in young cocaine users, with no risk factors
for coronary disease andwho did not recognise chest pain
as a possible clinical presentation of MI. The reliability of
the reported type and duration of chest pain cannot be
ensured because the patients did not visit the emergency
department, although prolonged chest pain can be
considered suggestive of cardiac origin. Finally, a reliable
evaluation should be done in this population because the
literature reports there is a risk (albeit small, at 6%) of
myocardial infarction. Further andmulticentre studies are
needed to evaluate the incidence and impact of cocaine
use on this young subset of patients [28].
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